RxDoctor Payments Data

Jobeth Rollandini, DPM

Podiatrist · Wheeling, WVNPI 1013204908

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Paratek Pharmaceuticals, Inc. at 35.5% of the total. 2025 is the largest year on record at $308, more than ten times the $6 reported in 2021. That places this record below the midpoint for podiatrist clinicians in WV, where the typical reported total is $1,242.

$584in general payments, 2019–2025

Across 38 payments — averaging $15.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paratek Pharmaceuticals, Inc.$208
  • Organogenesis Inc.$105
  • AbbVie$78
  • Smith+Nephew$47
  • Vertex$42
  • Kowa Pharmaceuticals America, Inc.$34
  • plus $72 from 5 others

What the payments were for

  • Food & beverage$584100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$584 in reported general payments places this provider in the 20th percentile of 37 podiatrist providers in West Virginia.

See all podiatrist providers in West Virginia

Medicare billing

Part B allowed, 2024
$146,470
Medicare patients
771
Services billed
2,239

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin52$1,560
Ciclopirox57$1,321
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha61$747
Diclofenac Sodium45$735
Ammonium Lactate36$688
ErythromycinErythromycin Base In Ethanol19$545
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip29$511
Duloxetine Hcl30$351
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav35$281
Gabapentin51$222
Colchicine17$201
Terbinafine Hcl24$187
Fluconazole31$169
Clindamycin Hcl14$146
Prednisone23$143

Paid to pharmacies, not to this prescriber.

Other podiatrist in Wheeling

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →